Ramin Najafi, Chief Executive Officer, 10% Owner at NovaBay Pharmaceuticals, Inc. (NBY), bought 50,000 shares at $0.65 ($33K) on 2014-12-12, disclosed to the SEC on 2014-12-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| NBY | BUY | 2014-12-11 | $12K | — | Filing → |
| NBY | BUY | 2014-12-08 | $16K | — | Filing → |
| NBY | BUY | 2014-12-04 | $13K | — | Filing → |